Antiviral therapy in chronic hepatitis C (G1) in Russia: cost and effectiveness
Genotype 1 HCV treatment in Russia assume as bitherapy (pegylated interferon – PG plus ribavirin – RBV) as three therapy based on HCV protease inhibitor such as telaprevir (TLV), boceprevir (BCV) or simeprevir (SMV) plus PG/RBV. Medical technologies characterize neither clinical effectiveness, safet...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2015-04-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/381 |